vs

Side-by-side financial comparison of AVISTA CORP (AVA) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

AVISTA CORP is the larger business by last-quarter revenue ($533.0M vs $455.6M, roughly 1.2× INNOSPEC INC.). AVISTA CORP runs the higher net margin — 13.3% vs 10.4%, a 2.9% gap on every dollar of revenue. On growth, AVISTA CORP posted the faster year-over-year revenue change (0.0% vs -2.4%). INNOSPEC INC. produced more free cash flow last quarter ($46.8M vs $-116.0M). Over the past eight quarters, INNOSPEC INC.'s revenue compounded faster (-4.6% CAGR vs -6.5%).

Avista Corporation is an American energy company which generates and transmits electricity and distributes natural gas to residential, commercial, and industrial customers. Approximately 1,550 employees provide electricity, natural gas, and other energy services to 359,000 electric and 320,000 natural gas customers in three western states. The service territory covers 30,000 square miles (78,000 km2) in eastern Washington, northern Idaho, and parts of southern and eastern Oregon, with a popul...

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

AVA vs IOSP — Head-to-Head

Bigger by revenue
AVA
AVA
1.2× larger
AVA
$533.0M
$455.6M
IOSP
Growing faster (revenue YoY)
AVA
AVA
+2.4% gap
AVA
0.0%
-2.4%
IOSP
Higher net margin
AVA
AVA
2.9% more per $
AVA
13.3%
10.4%
IOSP
More free cash flow
IOSP
IOSP
$162.8M more FCF
IOSP
$46.8M
$-116.0M
AVA
Faster 2-yr revenue CAGR
IOSP
IOSP
Annualised
IOSP
-4.6%
-6.5%
AVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVA
AVA
IOSP
IOSP
Revenue
$533.0M
$455.6M
Net Profit
$71.0M
$47.4M
Gross Margin
28.0%
Operating Margin
21.0%
10.3%
Net Margin
13.3%
10.4%
Revenue YoY
0.0%
-2.4%
Net Profit YoY
5.7%
167.3%
EPS (diluted)
$0.87
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVA
AVA
IOSP
IOSP
Q4 25
$533.0M
$455.6M
Q3 25
$403.0M
$441.9M
Q2 25
$411.0M
$439.7M
Q1 25
$617.0M
$440.8M
Q4 24
$532.8M
$466.8M
Q3 24
$393.7M
$443.4M
Q2 24
$402.1M
$435.0M
Q1 24
$609.4M
$500.2M
Net Profit
AVA
AVA
IOSP
IOSP
Q4 25
$71.0M
$47.4M
Q3 25
$29.0M
$12.9M
Q2 25
$14.0M
$23.5M
Q1 25
$79.0M
$32.8M
Q4 24
$67.2M
$-70.4M
Q3 24
$18.5M
$33.4M
Q2 24
$22.9M
$31.2M
Q1 24
$71.5M
$41.4M
Gross Margin
AVA
AVA
IOSP
IOSP
Q4 25
28.0%
Q3 25
26.4%
Q2 25
28.0%
Q1 25
28.4%
Q4 24
29.2%
Q3 24
28.0%
Q2 24
29.2%
Q1 24
31.1%
Operating Margin
AVA
AVA
IOSP
IOSP
Q4 25
21.0%
10.3%
Q3 25
14.9%
1.3%
Q2 25
13.9%
7.8%
Q1 25
20.3%
9.6%
Q4 24
19.1%
8.8%
Q3 24
12.4%
10.3%
Q2 24
13.5%
9.4%
Q1 24
16.6%
10.1%
Net Margin
AVA
AVA
IOSP
IOSP
Q4 25
13.3%
10.4%
Q3 25
7.2%
2.9%
Q2 25
3.4%
5.3%
Q1 25
12.8%
7.4%
Q4 24
12.6%
-15.1%
Q3 24
4.7%
7.5%
Q2 24
5.7%
7.2%
Q1 24
11.7%
8.3%
EPS (diluted)
AVA
AVA
IOSP
IOSP
Q4 25
$0.87
$1.90
Q3 25
$0.36
$0.52
Q2 25
$0.17
$0.94
Q1 25
$0.98
$1.31
Q4 24
$0.86
$-2.80
Q3 24
$0.23
$1.33
Q2 24
$0.29
$1.24
Q1 24
$0.91
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVA
AVA
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$19.0M
$292.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$1.3B
Total Assets
$8.4B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVA
AVA
IOSP
IOSP
Q4 25
$19.0M
$292.5M
Q3 25
$44.0M
$270.8M
Q2 25
$9.0M
$266.6M
Q1 25
$17.0M
$299.8M
Q4 24
$30.0M
$289.2M
Q3 24
$9.1M
$303.8M
Q2 24
$14.6M
$240.2M
Q1 24
$12.3M
$270.1M
Stockholders' Equity
AVA
AVA
IOSP
IOSP
Q4 25
$2.7B
$1.3B
Q3 25
$2.6B
$1.3B
Q2 25
$2.6B
$1.3B
Q1 25
$2.6B
$1.3B
Q4 24
$2.6B
$1.2B
Q3 24
$2.5B
$1.2B
Q2 24
$2.5B
$1.2B
Q1 24
$2.5B
$1.2B
Total Assets
AVA
AVA
IOSP
IOSP
Q4 25
$8.4B
$1.8B
Q3 25
$8.2B
$1.8B
Q2 25
$8.1B
$1.8B
Q1 25
$8.0B
$1.8B
Q4 24
$7.9B
$1.7B
Q3 24
$7.8B
$1.8B
Q2 24
$7.7B
$1.7B
Q1 24
$7.6B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVA
AVA
IOSP
IOSP
Operating Cash FlowLast quarter
$75.0M
$61.4M
Free Cash FlowOCF − Capex
$-116.0M
$46.8M
FCF MarginFCF / Revenue
-21.8%
10.3%
Capex IntensityCapex / Revenue
35.8%
3.2%
Cash ConversionOCF / Net Profit
1.06×
1.30×
TTM Free Cash FlowTrailing 4 quarters
$-101.0M
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVA
AVA
IOSP
IOSP
Q4 25
$75.0M
$61.4M
Q3 25
$170.0M
$39.3M
Q2 25
$40.0M
$9.3M
Q1 25
$184.0M
$28.3M
Q4 24
$89.8M
$25.7M
Q3 24
$127.2M
$73.5M
Q2 24
$126.8M
$4.7M
Q1 24
$190.1M
$80.6M
Free Cash Flow
AVA
AVA
IOSP
IOSP
Q4 25
$-116.0M
$46.8M
Q3 25
$37.0M
$25.0M
Q2 25
$-103.0M
$-3.7M
Q1 25
$81.0M
$19.9M
Q4 24
$-37.8M
$13.6M
Q3 24
$-27.0M
$65.8M
Q2 24
$-5.7M
$-6.2M
Q1 24
$71.4M
$69.9M
FCF Margin
AVA
AVA
IOSP
IOSP
Q4 25
-21.8%
10.3%
Q3 25
9.2%
5.7%
Q2 25
-25.1%
-0.8%
Q1 25
13.1%
4.5%
Q4 24
-7.1%
2.9%
Q3 24
-6.9%
14.8%
Q2 24
-1.4%
-1.4%
Q1 24
11.7%
14.0%
Capex Intensity
AVA
AVA
IOSP
IOSP
Q4 25
35.8%
3.2%
Q3 25
33.0%
3.2%
Q2 25
34.8%
3.0%
Q1 25
16.7%
1.9%
Q4 24
23.9%
2.6%
Q3 24
39.2%
1.7%
Q2 24
33.0%
2.5%
Q1 24
19.5%
2.1%
Cash Conversion
AVA
AVA
IOSP
IOSP
Q4 25
1.06×
1.30×
Q3 25
5.86×
3.05×
Q2 25
2.86×
0.40×
Q1 25
2.33×
0.86×
Q4 24
1.34×
Q3 24
6.88×
2.20×
Q2 24
5.55×
0.15×
Q1 24
2.66×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVA
AVA

Segment breakdown not available.

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons